Clinical trial
The Effect of Intravenous Magnesium Sulfate Use on Intraoperative Remifentanil Consumption and Postoperative Pain in Laparoscopic Hysterectomy Cases
NCT05826119 is registered in ClinicalTrials.gov with Ondokuz Mayıs University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intravenous Magnesium Sulfate Use on Intraoperative Remifentanil Consumption and Postoperative Pain in Laparoscopic Hysterectomy Cases
- Lead sponsor
- Ondokuz Mayıs University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 20, 2024
- Completion date
- June 15, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
general anesthesia, laparoscopic hysterectomy, magnesium sulfate